+ Reply to Thread
Page 1 of 2 1 2 LastLast
Results 1 to 10 of 15
  1. #1
    Senior Member
    Join Date
    Jul 2011
    Location
    agaexperts.meteor.com
    Posts
    1,405

    Default Another Potential Cure From Israel (Not Pilox, but from Technion): Using bacteria

    http://2015.igem.org/Team:Technion_Israel

    Our solution strategy

    With the recent advances that established a strong relationship between the human microbiome and human health and disease, new frontiers in synthetic biology have begun to emerge concomitantly. Namely, rather than engineering a single bacterium chassis as is normally done in conventional synthetic biology applications, we have opted to devise an engineering strategy for a microbiome in order to address health-related problems.

    A national research program of the human microbiome has been established in the United States - The Human Microbiome Project (HMP). The goal of the HMP is to demonstrate that there are opportunities to improve human health through monitoring and/or manipulation of the human microbiome 10. New and promising startups have been established based on the idea of the utilization and adaptation of the human microbiome to our needs. For example, AOBiome, LLC. created a dedicated line of products (named ‘Motherdirt’) - the first line of products for the skin made, which includes live bacteria incorporated into the product itself (Ammonia Oxidizing Bacteria) 11. This product was publicized extensively in the media - In “The New York Times” and “Good Morning America”. In the past several years, several other big cosmetic companies have released products incorporating natural bacteria - “Clinique Redness Solutions Makeup SPF 15” by Clinique and “Cosmeceuticals Unstress Total Serenity Serums” by Christina are few examples of this promising market 12.

    Using this trend in research and cosmetics, we decided to develop a new synthetic biology approach for engineering a microbiome. In our approach, we opt to genetically alter one or more of the bacterial populations that are naturally present to secrete a particular enzyme. Thus, on the one hand we minimally perturb the natural microbiome, while on the other we co-opt it to produce a sustainable treatment of some sort.

    We decided to apply this approach on the problem of male pattern baldness. We planned to alter the most abundant bacterium which is naturally found on our scalp (Bacillus subtilis) 15 and genetically engineer it for our needs: taking advantage of its natural protein secretion pathways in order to secrete a DHT-reducing enzyme (as will be explained in the following paragraph). This new application of the human microbiome usage is a path, in our opinion, to solve a variety of conditions and enhance overall wellness in the future.

    Solution

    The proposed solution is to incorporate the gene of a DHT-inactivating enzyme into a bacterium that is naturally found on our scalp (B.subtillis). These transgenic microorganisms will be applied on the patient's scalp, and will secrete the enzyme to their environment, providing a constantly renewed supply of the treatment. The proposed DHT-inactivating enzyme is the 3α-hydroxysteroid dehydrogenase (3α-HSD) enzyme. DHT is inactivated by the 3α-HSD to form 3α-androstanediol 13, as shown in figure 1 below.


    Figure 1:Androgen metabolism in the human prostate13
    3α-HSD exists naturally in human prostate, performing the mentioned reaction14. However, according to previous research, the isoform originated from rat liver has greater specificity to DHT than the human isoform 16. Therefore, we chose to use the sequence of AKR1C9 for our project. We altered the sequence in order to delete forbidden restriction sites according to the iGEM regulations for BioBricks.

    The components of the project

    An illustration of our proposed solution and project components can be seen in Figure 2.


    Figure 2: Schematic illustration of the project design, incorporating its main components: Bacillus subtilis (illustrated by the blue bacteria) which secretes 3α-HSD (illustrated by the yellow circles), engineered E.coli (illustrated by the red bacteria) for NADPH molecule (illustrated by the green circles) overproduction, and a comb as a tool to create a user-friendly experience.
    In order to better focus on the many different components of our project, we split up into groups to tackle each component: Expression of the 3α-HSD enzyme, secretion of the enzyme, and cofactor production. Additionally, a group worked on developing a comb- a tool which could provide a user-friendly solution for the consumer in applying our product to the scalp. For more information about each sub-group, enter the page from the menu above, or visit the links below:
    Secretion
    Expression
    Cofactor
    Comb and Design
    Results
    Modeling

  2. #2
    Senior Member
    Join Date
    Jun 2014
    Posts
    213

    Default

    very interesting.. makes dht useless? Seems like this + something with the mechanisms of something similar to replicel could be a damn near cure eh.

    i'll give it 25 years.

  3. #3
    Junior Member
    Join Date
    Aug 2014
    Posts
    23

    Default

    This is the most fun approach to MPB I've ever heard of - and it's so elegant. But the pitfalls I see is that it might be not effective enough (worse than propecia) and that the minoxidil containing products will kill off the bacteria too much due to all that alcohol.

  4. #4
    Senior Member
    Join Date
    Dec 2012
    Posts
    226

    Default

    Wow that has to be one of the most novel approaches to treating MPB. Hopefully something tangible comes out of it, but I'm not holding my breath.

  5. #5
    Senior Member
    Join Date
    Apr 2015
    Posts
    413

    Default

    Wasn't that what the 3D comb thread was about?

  6. #6
    Junior Member
    Join Date
    Aug 2014
    Posts
    23

    Default

    They first want to try it on mice...wow...really? Why not go directly to human testing? Ok testing rules are testing rules, but this sounds like the safest thing ever and they want to waste their time on those little critters.. good grief

  7. #7
    Member
    Join Date
    Aug 2014
    Posts
    61

    Default

    In fact, wasn't there a poster a while ago who mentioned some effective underground treatment (if not cure) that uses or would use bacteria? I mean, it read as the biggest absurdity ever, but it does make you wonder ...
    Anyway, am I misunderstanding something or would this basically be the equivalent of a topical DHT-blocking treatment but with a resident bacteria population doing the work for you? The question is, what does that mean in terms of possible side effects?

  8. #8

  9. #9
    Senior Member
    Join Date
    Aug 2015
    Posts
    342

    Default

    Quote Originally Posted by Kokles View Post
    They first want to try it on mice...wow...really? Why not go directly to human testing? Ok testing rules are testing rules, but this sounds like the safest thing ever and they want to waste their time on those little critters.. good grief
    On the plus side... I don't think mice trials take that long. A quick safety trial might as well happen, we've already waited this long.

  10. #10
    Senior Member
    Join Date
    May 2014
    Posts
    803

    Default

    Quote Originally Posted by Follisket View Post
    In fact, wasn't there a poster a while ago who mentioned some effective underground treatment (if not cure) that uses or would use bacteria? I mean, it read as the biggest absurdity ever, but it does make you wonder ...
    Anyway, am I misunderstanding something or would this basically be the equivalent of a topical DHT-blocking treatment but with a resident bacteria population doing the work for you? The question is, what does that mean in terms of possible side effects?
    In muscle tissue for example DHT doesn't play a big role in muscle hypertrophy. This is primarily because it works in an autocrine/paracrine way. So it's primarily active in the tissue where it is synthesized. As you may know there are 3 forms of 5 alpha reductase. Only one of them is active is in muscle tissue, type 3.

    However the second thing is and that is important for the story here is that in muscle tissue DHT get's metabolized to an inactive androgen by the enzyme 3a-HSD. This is because this enzyme is abundant in muscle tissue. However this is not the case in our scalp/hair follicle. If we could engineer bacteria to do the same for our (local) hair follicle environment then it would make DHT kinda useless. In theory it should be completely side effect free if done correctly.

Similar Threads

  1. Potential new hair loss cure
    By gruaige in forum Cutting Edge / Future Treatments
    Replies: 4
    Last Post: 07-19-2021, 10:29 PM
  2. Anyone here from Israel?
    By IvanXproject in forum Hair Loss Treatments
    Replies: 16
    Last Post: 02-12-2017, 03:19 PM
  3. Vitamin-Boosted Stem Cells Reveal Potential to Cure Baldness
    By failly in forum Cutting Edge / Future Treatments
    Replies: 5
    Last Post: 09-17-2015, 09:26 AM
  4. Potential Cure?
    By kantian in forum Cutting Edge / Future Treatments
    Replies: 1
    Last Post: 04-11-2015, 07:45 AM
  5. Pilox is the Answer
    By NeedHairASAP in forum Cutting Edge / Future Treatments
    Replies: 21
    Last Post: 12-09-2013, 03:45 PM

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts

» IAHRS

hair transplant surgeons

» The Bald Truth

» Recent Threads

1800 graft repair case results by Dr. Lindsey
Yesterday 08:38 AM
Last Post By Dr. Lindsey
Yesterday 08:38 AM
Navigating the German Job Market as a Kenyan Citizen
11-04-2023 06:31 AM
Last Post By Keegan212
Yesterday 03:51 AM
DR HAKAN DOGANAY/ 4500 GRAFTS / Implanter Pen+FUE
03-26-2024 04:15 PM
Last Post By Hakan Doganay, MD
03-26-2024 04:15 PM
The Mane Event for Thursday, June 15th, 2023
06-15-2023 02:59 PM
Last Post By gisecit34
03-26-2024 08:05 AM